|
|
|
Insider
Information: |
Forbes Christopher |
Relationship: |
Director, 10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
12,757,318 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$10,279,719 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
12,757,318 |
|
|
Total
Value |
$10,279,719 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Eloxx Pharmaceuticals Inc |
ELOX |
Director, 10% Owner |
2012-11-26 |
12,757,318 |
2004-01-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2004-01-23 |
4 |
B |
$0.00 |
$0 |
D/D |
31,646 |
579,569 |
2.31 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2005-11-28 |
4 |
B |
$1.49 |
$44,700 |
D/D |
30,000 |
609,569 |
2.39 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2006-03-17 |
4 |
B |
$1.50 |
$60,000 |
D/D |
40,000 |
649,569 |
2.39 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2006-10-11 |
4 |
A |
$1.07 |
$944,812 |
D/D |
883,002 |
1,532,571 |
0 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2007-12-10 |
4 |
B |
$0.54 |
$28,928 |
D/D |
54,000 |
1,586,571 |
3.92 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2007-12-11 |
4 |
B |
$0.78 |
$38,870 |
D/D |
50,000 |
1,636,571 |
3.92 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2007-12-12 |
4 |
B |
$0.94 |
$136,598 |
D/D |
146,000 |
1,782,571 |
3.92 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2007-12-13 |
4 |
B |
$0.95 |
$47,500 |
D/D |
50,000 |
1,832,571 |
3.92 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2007-12-14 |
4 |
B |
$0.91 |
$13,601 |
D/D |
15,000 |
1,847,571 |
3.92 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2008-02-20 |
4 |
B |
$0.70 |
$10,823 |
D/D |
15,000 |
1,862,571 |
3.92 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2008-02-21 |
4 |
B |
$0.75 |
$29,725 |
D/D |
38,300 |
1,900,871 |
3.92 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2008-02-22 |
4 |
B |
$0.77 |
$18,340 |
D/D |
23,300 |
1,924,171 |
3.92 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2008-02-25 |
4 |
B |
$0.76 |
$7,723 |
D/D |
10,000 |
1,934,171 |
3.84 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2008-02-26 |
4 |
B |
$0.74 |
$11,544 |
D/D |
15,200 |
1,949,371 |
3.92 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2008-02-27 |
4 |
B |
$0.78 |
$78 |
D/D |
100 |
1,949,471 |
3.84 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2008-02-29 |
4 |
B |
$0.79 |
$711 |
D/D |
900 |
1,950,371 |
3.84 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2008-03-06 |
4 |
B |
$0.81 |
$10,401 |
D/D |
12,400 |
1,962,771 |
3.92 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2008-03-07 |
4 |
B |
$0.85 |
$16,928 |
D/D |
19,800 |
1,982,571 |
3.92 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2008-03-10 |
4 |
B |
$0.84 |
$462 |
D/D |
550 |
1,983,121 |
3.84 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2008-03-11 |
4 |
B |
$0.86 |
$12,972 |
D/D |
14,900 |
1,998,021 |
3.92 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2008-03-12 |
4 |
B |
$0.84 |
$8,884 |
D/D |
10,100 |
2,008,121 |
3.84 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2008-03-13 |
4 |
B |
$0.88 |
$2,464 |
D/D |
2,800 |
2,010,921 |
3.84 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2008-03-14 |
4 |
B |
$0.88 |
$13,574 |
D/D |
15,100 |
2,026,021 |
3.92 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2008-12-12 |
4 |
B |
$0.60 |
$2,400 |
D/D |
4,000 |
2,036,021 |
3.84 |
- |
|
ELOX |
Eloxx Pharmaceuticals Inc |
Director |
|
2008-12-15 |
4 |
B |
$0.60 |
$3,929 |
D/D |
6,000 |
2,036,021 |
3.84 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|